Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.

Expression of FOXP3, CD68, and CD20 at diagnosis in the microenvironment of classical Hodgkin lymphoma is predictive of outcome.

PURPOSE: The immune microenvironment is key to the pathophysiology of classical Hodgkin lymphoma (CHL). Twenty percent of patients experience failure of their initial treatment, and others receive excessively toxic treatment. Prognostic scores and biomarkers have yet to influence outcomes significa...

Full description

Bibliographic Details
Main Authors:	Greaves, P, Clear, A, Coutinho, R, Wilson, A, Matthews, J, Owen, A, Shanyinde, M, Lister, T, Calaminici, M, Gribben, J
Format:	Journal article
Language:	English
Published:	2013

Similar Items

CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
by: Harris Jonathan A, et al.
Published: (2012-01-01)

The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt
by: Osama Mohamed, et al.
Published: (2020-02-01)

Prognostic significance of CD163- and CD68-expressing macrophages in nodular sclerosis Hodgkin lymphoma
by: E. A. Perfilova, et al.
Published: (2022-01-01)

Relationship of Tumor-Associated Macrophage Population Detected by CD68 PG-M1, CD68 KP1, and CD163 with Latent EBV Infection and Prognosis in Classical Hodgkin Lymphoma
by: Hanife Seda MAVILI, et al.
Published: (2021-05-01)

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
by: YuanBo Xue, et al.
Published: (2021-02-01)

Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist
by: Nicole A. Carreau, et al.
Published: (2019-05-01)

Prognostic Markers within the Tumour Microenvironment in Classical Hodgkin Lymphoma
by: Arina Martynchyk, et al.
Published: (2023-10-01)

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma
by: Yucai Wang, et al.
Published: (2018-04-01)

Role of ADAM10 as a CD30 Sheddase in Classical Hodgkin Lymphoma
by: Hinrich P. Hansen, et al.
Published: (2020-03-01)

P014 (0098) CD47 IS EXPRESSED ON HODGKIN REED STERNBERG CELLS IN CLASSICAL HODGKIN LYMPHOMA
Published: (2018-10-01)

The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.
by: Brown, P, et al.
Published: (2005)

Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications
by: Vasileios Georgoulis, et al.
Published: (2023-06-01)

Inflammatory microenvironment in classical Hodgkin’s lymphoma with special stress on mast cells
by: Domenico Ribatti, et al.
Published: (2022-10-01)

CD20 positivity in classical Hodgkin′s lymphoma: Diagnostic challenge or targeting opportunity
by: Barakzai Muhammad, et al.
Published: (2009-01-01)

Acquired Natural Killer Cell Dysfunction in the Tumor Microenvironment of Classic Hodgkin Lymphoma
by: Jodi Chiu, et al.
Published: (2018-02-01)

Identification of a novel monocytic phenotype in Classic Hodgkin Lymphoma tumor microenvironment.
by: Ginell R Post, et al.
Published: (2019-01-01)

CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma.
by: Young Wha Koh, et al.
Published: (2014-01-01)

Genetics of classical Hodgkin Lymphoma
by: Gianluca Schiavoni, et al.
Published: (2018-06-01)

P035: CRISPR/Cas9-mediated knockout reveals an important role of CD30 in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma
by: Annika L. Kilian, et al.
Published: (2022-10-01)

Controversies in the Treatment of Classical Hodgkin Lymphoma
by: Dennis A. Eichenauer, et al.
Published: (2018-10-01)

Functional aspects of the CD30 gene in Hodgkin’s lymphoma and anaplastic large cell lymphoma
by: Desiree S. Ho, et al.
Published: (2011-12-01)

Composite follicular lymphoma and classic Hodgkin lymphoma
by: Han-Na Kim, et al.
Published: (2022-01-01)

CD3+, CD56+, CD4−, CD8−, CD20−, CD30− Peripheral T-Cell Non-Hodgkin's Lymphoma: A Rare Case Report
by: Ashish Jagati, et al.
Published: (2017-01-01)

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
by: Alessandro Cellini, et al.
Published: (2023-05-01)

Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
by: Pengcheng Zhao, et al.
Published: (2024-01-01)

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
by: Eline A. M. Zijtregtop, et al.
Published: (2022-08-01)

Hodgkin Lymphoma: A Special Microenvironment
by: Giuseppina Opinto, et al.
Published: (2021-10-01)

Evolution of drug therapy for classical Hodgkin lymphoma
by: N. Y. Samaneva, et al.
Published: (2022-09-01)

Altered Frequencies of CD4+ CD25+ Foxp3+ and CD8+ CD25+ Foxp3+ Regulatory T Cells in Pre-eclampsia
by: Maryam Zare, et al.
Published: (2018-12-01)

Aberrant synaptophysin expression in classic Hodgkin lymphoma
by: Soyoung Im, et al.
Published: (2022-11-01)

The Grey Zones of Classic Hodgkin Lymphoma
by: Jan Bosch-Schips, et al.
Published: (2022-01-01)

Classical Hodgkin’s Lymphoma Presenting as Erythroderma
by: Kumar Parimalam, et al.
Published: (2022-11-01)

Novel Approaches in Molecular Characterization of Classical Hodgkin Lymphoma
by: Diede A. G. van Bladel, et al.
Published: (2022-06-01)

The Tumor Microenvironment in Classic Hodgkin’s Lymphoma in Responder and No-Responder Patients to First Line ABVD Therapy
by: Roberto Tamma, et al.
Published: (2023-05-01)

Impact of Cox2, CD163, and Microvessel Density Expression on the Prediction of Relapse and Patients’ Outcome in Classical Hodgkin Lymphoma
by: Rania Makboul, et al.
Published: (2022-04-01)

High Counts of CD68+ and CD163+ Macrophages in Mantle Cell Lymphoma Are Associated With Inferior Prognosis
by: Philippa Li, et al.
Published: (2021-08-01)

SNP RS6457327 ON CHROMOSOME 6P PREDICTS TRANSFORMATION OF FOLLICULAR LYMPHOMA
by: Wrench, J, et al.
Published: (2010)

Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients
by: Sonia Furgiuele, et al.
Published: (2022-06-01)

Dissecting the regulatory microenvironment of a large animal model of non-Hodgkin lymphoma: evidence of a negative prognostic impact of FOXP3+ T cells in canine B cell lymphoma.
by: Dammy Pinheiro, et al.
Published: (2014-01-01)

P038: HLA expression patterns of Hodgkin-Reed-Sternberg cells shape a spatially arranged tumor microenvironment in classical Hodgkin lymphoma
by: Berit Müller-Meinhard, et al.
Published: (2022-10-01)